Loading...
Thumbnail Image
Publication

Nucleic Acid Aptamers Protect Against Lead (Pb(II)) Toxicity [preprint]

Anwar, Afreen
De Ayreflor Reyes, Solimar Ramis
John, Aijaz Ahmad
Breiling, Erik
O'Connor, Abigail M
Reis, Stephanie
Shim, Jae-Hyuck
Shah, Ali Asghar
Srinivasan, Jagan
Farny, Natalie G
Embargo Expiration Date
Abstract

Lead (Pb(II)) is a pervasive heavy metal toxin with many well-established negative effects on human health. Lead toxicity arises from cumulative, repeated environmental exposures. Thus, prophylactic strategies to protect against the bioaccumulation of lead could reduce lead-associated human pathologies. Here we show that DNA and RNA aptamers protect C. elegans from toxic phenotypes caused by lead. Reproductive toxicity, as measured by brood size assays, is prevented by co-feeding of animals with DNA or RNA aptamers. Similarly, lead-induced behavioral anomalies are also normalized by aptamer feeding. Further, cultured human HEK293 and primary murine osteoblasts are protected from lead toxicity by transfection with DNA aptamers. The osteogenic development, which is decreased by lead exposure, is maintained by prior transfection of lead-binding DNA aptamers. Aptamers may be an effective strategy for the protection of human health in the face of increasing environmental toxicants.

Source

Anwar A, De Ayreflor Reyes SR, John AA, Breiling E, O'Connor AM, Reis S, Shim JH, Shah AA, Srinivasan J, Farny NG. Nucleic Acid Aptamers Protect Against Lead (Pb(II)) Toxicity. bioRxiv [Preprint]. 2024 Mar 31:2024.03.28.587288. doi: 10.1101/2024.03.28.587288. PMID: 38585880; PMCID: PMC10996642.

Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
10.1101/2024.03.28.587288
PubMed ID
38585880
Other Identifiers
Notes

This article is a preprint. Preprints are preliminary reports of work that have not been certified by peer review.

Funding and Acknowledgements
Corresponding Author
Related Resources
Related Resources
Repository Citation
Rights
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.Attribution-NonCommercial-NoDerivatives 4.0 International